Product Information
LOTEPREDNOL ETABONATE 0.2% DRP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $30.7171 per ML under NDC 82260036105. Its NADAC has been published 124 times since May 22, 2024.
FDA first approved this application on Mar 9, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/mL
Manufacturer
Bausch & Lomb Americas Inc.NDC
82260036105
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020803FDA Approved
3/9/1998
TE Code
AB
On Market Since
2/9/2024
Pharmacological Classes
Price Statistics
The NADAC for LOTEPREDNOL ETABONATE 0.2% DRP has been published 124 times since May 22, 2024, and over the history we have for it it has risen 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $30.7171 per ML |
|---|---|
| All-time high | $40.9627 (Nov 13, 2024) |
| All-time low | $26.0966 (Jul 17, 2024) |
| 52-week high | $35.8878 |
| 52-week low | $30.4534 |
| Median price | $34.9619 |
| Average price | $34.0697 |
| Largest weekly change | +21.3% (Aug 21, 2024) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Americas Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
loteprednol etabonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOTEPREDNOL ETABONATE 0.2% DRP?
The current National Average Drug Acquisition Cost (NADAC) for LOTEPREDNOL ETABONATE 0.2% DRP, manufactured by Bausch & Lomb Americas Inc., is $30.7171 per ML (NDC 82260036105), effective Sep 30, 2026.
How has the price of LOTEPREDNOL ETABONATE 0.2% DRP changed over time?
Over the history we have for it, the NADAC for LOTEPREDNOL ETABONATE 0.2% DRP has risen 7.2%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for LOTEPREDNOL ETABONATE 0.2% DRP?
Since May 22, 2024, the NADAC for LOTEPREDNOL ETABONATE 0.2% DRP has ranged from a low of $26.0966 (Jul 17, 2024) to a high of $40.9627 (Nov 13, 2024), with a median of $34.9619 per ML.
Are there cheaper alternatives to LOTEPREDNOL ETABONATE 0.2% DRP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOTEPREDNOL ETABONATE 0.2% DRP in a comparable dosage form, but none are currently priced below it.
Who manufactures LOTEPREDNOL ETABONATE 0.2% DRP?
LOTEPREDNOL ETABONATE 0.2% DRP (NDC 82260036105) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.